The “green nail” phenomenon in ICG-enhanced fluorescence optical imaging - a potential tool for the differential diagnosis of psoriatic arthritis

2019 ◽  
Vol 17 (2) ◽  
pp. 138-147 ◽  
Author(s):  
Oliver Wiemann ◽  
Stephanie G. Werner ◽  
Hans-Eckhard Langer ◽  
Marina Backhaus ◽  
René Chatelain
2014 ◽  
Vol 73 (Suppl 2) ◽  
pp. 80.1-80
Author(s):  
O. Wiemann ◽  
S.G. Werner ◽  
H. Röver ◽  
G. Lind-Albrecht ◽  
S. Mettler ◽  
...  

2013 ◽  
Vol 71 (Suppl 3) ◽  
pp. 613.1-613
Author(s):  
S.G. Werner ◽  
U. Käßer ◽  
C. Amberger ◽  
M. Piesga ◽  
F. Spiecker ◽  
...  

2020 ◽  
Author(s):  
Angelique Schmidt ◽  
Anne-Marie Glimm ◽  
Ida Kristin Haugen ◽  
Paula Hoff ◽  
Gabriela Schmittat ◽  
...  

Abstract Objectives: To investigate the frequency of subclinical skin inflammation in both hands by fluorescence optical imaging (FOI) in patients with psoriasis/psoriatic arthritis (Pso/PsA) vs. rheumatoid arthritis (RA) and healthy individuals, and to correlate these findings with cardiovascular (CV) risk factors.Patients and Methods: The FOI scans were analyzed retrospectively to detect clinically invisible skin enhancement (0-3 scale) in both hands without relationship to underlying joints or blood vessels. We further characterized the FOI patterns and sorted the scans into groups based on the assumed diagnosis (Pso/PsA, RA and healthy controls), which was compared with the physician’s diagnosis. Furthermore, the associations between CV risk factors and imaging findings were investigated by regression analyses.Results: We included FOI scans of patients with Pso/PsA (n=80), RA (n=78) and healthy controls (n=25). Subclinical skin enhancement on the back of their hands was more common in Pso/PsA (72.5%) than in RA patients (20.5%) and healthy individuals (28.0%) (p<0.001). Based on the FOI pattern, the majority of patients with Pso/PsA (72.5%), RA (76.9%) and healthy controls (68.0%) were classified correctly using the physician-based diagnosis as reference (overall agreement of 74%, kappa=0.57). No CV risk factors except body weight (kg) was associated with subclinical skin enhancement (OR 1.04, 95% CI 1.02-1.06; p<0.001). Conclusion: Subclinical subdermal skin inflammation was common in Pso/PsA patients using FOI. Based on the FOI pattern, most patients with Pso/PsA and were classified with the correct diagnosis. We demonstrated an important influence of the body weight on our FOI results. FOI may be a helpful novel tool to study microcirculation in rheumatic diseases with skin involvement.


2013 ◽  
Vol 72 (Suppl 3) ◽  
pp. A759.3-A760 ◽  
Author(s):  
S. G. Werner ◽  
F. Spiecker ◽  
S. Mettler ◽  
G. Lind-Albrecht ◽  
O. Wiemann ◽  
...  

2021 ◽  
Vol 80 (Suppl 1) ◽  
pp. 983.2-983
Author(s):  
B. Drude ◽  
Ø. Maugesten ◽  
S. G. Werner ◽  
G. R. Burmester ◽  
J. Berger ◽  
...  

Background:Fluorescence Optical Imaging (FOI) utilises the fluorophore indocyanine green (ICG) to reflect enhanced microcirculation in hand and finger joints due to inflammation.Objectives:We wanted to assess the interreader reliability of FOI enhancement in patients with hand osteoarthritis (OA) and psoriatic arthritis (PsA). Furthermore, predefined typical morphologic patterns were included to determine the ability of FOI to discriminate between both diagnoses.Methods:An atlas with example images of grade 0-3 in different joint groups and typical morphologic patterns (‘streaky signals’[1], ‘green/blue nail sign’[2], ‘Werner sign’[3,4], and ‘Bishop’s crozier sign’) of PsA and hand OA was created. Two readers scored all joints in both hands (30 in total) of 20 cases with hand OA and PsA. The cases were randomly mixed and both readers were blinded to diagnosis. Each joint was rated on a semiquantitative scale from 0 to 3 in five different images (PrimaVista Mode (PVM), phase 1, 2 (first and middle image), and 3) during the FOI sequence according to the scoring method FOIAS (fluorescence optical imaging activity score)[1,3]. Interreader reliability on scoring joint enhancement was calculated using linear weighted Cohen’s kappa (κ). Agreement on diagnosis (hand OA vs. PsA) and different morphologic patterns was assessed by calculating (regular) Cohen’s kappa.Results:Overall agreement on scoring joint enhancement (all phases) was substantial (κ = 0.75), with greatest consensus in phase 2 first (κ = 0.75) and lowest agreement in phase 1 (κ = 0.46). Reliability varied in different joint groups (wrist, MCP, (P)IP, DIP), with almost perfect overall agreement on PIP joint affection (κ = 0.81), substantial agreement on wrist (κ = 0.69) and DIP joint affection (κ = 0.63), and moderate agreement on MCP joint affection (κ = 0.49) across all phases. Consensus on morphologic patterns showed overall fair agreement (κ = 0.37) with a similar kappa value on the ability to discriminate between both diagnoses (κ = 0.3).Conclusion:Joint enhancement in FOI can be reliably assessed using a predefined scoring method. The ability of FOI to differentiate between hand OA and PsA seems to be limited. Clearer definition and more training might be needed to better agree on morphologic patterns in FOI.References:[1] Glimm AM, Werner SG, Burmester GR, et al. Ann Rheum Dis. 2016 Mar;75(3):566-570[2] Wiemann O, Werner SG, Langer HE, et al. J Dtsch Dermatol Ges. 2019 Feb;17(2):138-148[3] Werner SG, Langer HE, Ohrndorf S, et al. Ann Rheum Dis. 2012 Apr;71(4):504-510[4] Zeidler H 2019. Fluoreszenzoptische Bildgebung. In: Zeidler H, Michel BA. Differenzialdiagnose rheumatischer Erkrankungen 5. Aufl. Springer, Heidelberg, S. 88-89Disclosure of Interests:Benedict Drude: None declared, Øystein Maugesten: None declared, Stephanie Gabriele Werner: None declared, Gerd Rüdiger Burmester: None declared, Jörn Berger Employee of: Xiralite GmbH, Ida K. Haugen: None declared, Sarah Ohrndorf: None declared


Sign in / Sign up

Export Citation Format

Share Document